Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Current Leases (2019 - 2025)

Lifecore Biomedical, Inc. \De\ has reported Current Leases over the past 7 years, most recently at $4.0 million for Q1 2025.

  • For Q1 2025, Current Leases fell 4.64% year-over-year to $4.0 million; the TTM value through Feb 2025 reached $4.0 million, down 4.64%, while the annual FY2024 figure was $4.0 million, 212.05% up from the prior year.
  • Current Leases for Q1 2025 was $4.0 million at Lifecore Biomedical, Inc. \De\, down from $4.1 million in the prior quarter.
  • Over five years, Current Leases peaked at $4.4 million in Q1 2022 and troughed at $977000.0 in Q2 2021.
  • A 5-year average of $2.8 million and a median of $4.0 million in 2024 define the central range for Current Leases.
  • On a YoY basis, Current Leases climbed as much as 704.0% in 2021 and fell as far as 77.91% in 2021.
  • Year by year, Current Leases stood at $1.2 million in 2021, then surged by 255.83% to $4.3 million in 2022, then tumbled by 72.47% to $1.2 million in 2023, then soared by 245.01% to $4.1 million in 2024, then decreased by 3.64% to $4.0 million in 2025.
  • Business Quant data shows Current Leases for LFCR at $4.0 million in Q1 2025, $4.1 million in Q4 2024, and $4.1 million in Q3 2024.